Landmark Trial Begins: 29 States Say Meta Deliberately Addicted Children to Facebook and Instagram
Potential $200B penalties could reshape platforms.
Already have an account? Sign in.
Potential $200B penalties could reshape platforms.
Merck and Moderna’s personalized mRNA vaccine with Keytruda reduced melanoma recurrence in a 1,137-patient Phase 3 trial—the first late-stage win for an mRNA cancer vaccine.
Target posts strong Q2 results and lifts full-year guidance on turnaround progress, yet mixed investor reaction reflects uneven categories and one-time tariff boosts.
Lowe’s Q2 sales missed estimates at $25.96B as shoppers delay big renovations. Company now expects flat comparable sales and lowers full-year guidance.